Clinical Trial

Urinary Tract Infections Caused by Extended-spectrum Beta-lactamase-producing Enterobacteria

Study acronym: EBLSE
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 4, 2025 (before its estimated December 24, 2025 completion). Its status may not reflect the trial's current state.
Summary
Urinary tract infections (UTIs) are one of the most common pathologies encountered in general practice. However, with increasing bacterial resistance to antibiotics, their treatment is becoming increasingly complex. Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) pose a particular challenge due to their increased resistance to many commonly used antibiotics. The aim of this thesis is to study the management of such infections by general practitioners in Bas-Rhin and to suggest possible avenues for improvement.
Trial Details
NCT Number NCT06910878
Lead Sponsor University Hospital, Strasbourg, France
Conditions Urinary Tract Infections
Enrollment 100 participants
Start Date 2024-10-24
Primary Completion 2025-12-24 (estimated)
Study Completion 2025-12-24 (estimated)
Updated on ClinicalTrials.gov 2025-04-04